- জেনেরিক নাম
- Ambrisentan
- শক্তি
- 10 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Square Pharmaceuticals PLC.
Ambrisan 10 Tablet
Ambrisan 10 Tablet সম্পর্কে
Ambrisan 10 হলো Ambrisentan-এর একটি ব্র্যান্ড, শক্তি ১০ mg, ট্যাবলেট আকারে। Ambrisan 10-এর সাথে Ambrisentan-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এটি তৈরি করে Square Pharmaceuticals PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Ambrisentan-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।
Ambrisan 10 Tablet কী?
Ambrisan 10 is a 10 mg tablet containing the medicine ambrisentan. It belongs to a group of medicines that act on endothelin receptors in the blood vessels. It is prescribed for adults with pulmonary arterial hypertension, where blood pressure in the lungs is raised. In this condition it is used to help improve the ability to exercise and to delay worsening of the disease. Whether it suits a particular person depends on their overall health and other conditions, so the treating doctor decides if it is appropriate.
Ambrisan 10-এর ব্যবহার
Ambrisan 10 is used in adults for pulmonary arterial hypertension. This is a condition in which blood pressure in the arteries of the lungs is higher than normal. Treatment with ambrisentan aims to improve how well a person can exercise and to delay the disease getting worse. It is not a general treatment for everyday high blood pressure. Your doctor will assess your condition and decide whether this medicine is suitable for you.
Ambrisan 10 কীভাবে ব্যবহার করবেন
Ambrisan 10 is a tablet that is swallowed, and it can be taken with or without food. The dose and how long you take it are decided by your doctor, who will also adjust treatment based on how you respond and tolerate it. Do not change the dose yourself. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up. Keep all follow-up appointments so your progress can be checked.
Ambrisan 10-এর পার্শ্বপ্রতিক্রিয়া
Some people may notice side effects while taking ambrisentan. Fluid retention, such as swelling of the ankles or legs, is a known effect of medicines in this group and can also be a sign of the underlying condition getting worse. Changes in blood counts, including a fall in haemoglobin, have been seen with this type of medicine. Tell your doctor about swelling, breathlessness or unusual tiredness. Your doctor or pharmacist can explain what to watch for and how side effects are managed.
সতর্কতা ও নিরাপত্তা
Ambrisan 10 must not be used during pregnancy, and pregnancy should be ruled out before starting it and prevented during treatment and for a period after stopping. It is not recommended while breastfeeding. It should not be used in people with idiopathic pulmonary fibrosis. Swelling and sudden breathlessness during treatment need medical attention. Your doctor will consider your liver and blood counts before and during treatment. Tell your doctor about all other medicines you take, and ask them first if you have any doubts about whether it is right for you.
সাধারণ প্রশ্ন
What is Ambrisan 10 used for and what kind of medicine is it?
It is used in adults with pulmonary arterial hypertension, a raised blood pressure in the lungs. It is an endothelin receptor blocker that acts on the blood vessels. It is not a routine blood pressure medicine, and your doctor will decide whether it is suitable for you.
How should Ambrisan 10 be taken?
Swallow the tablet, with or without food. Your doctor decides the dose and how long you take it, and may adjust it over time. Never change the dose on your own, and ask your doctor or pharmacist what to do if you miss a dose.
What does the generic name ambrisentan mean?
Ambrisentan is the generic name of the active ingredient in Ambrisan 10. It is the name used for the medicine itself, whatever brand it comes in. Knowing the generic name helps your doctor and pharmacist check what you are taking and any interactions with other medicines.
Can I become pregnant while taking this medicine?
It must not be used in pregnancy. Pregnancy needs to be ruled out before treatment starts and prevented during treatment and for a period after stopping. If you are pregnant, think you may be, or are planning a pregnancy, speak to your doctor before taking it.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ambrisentan is indicated for the treatment of Pulmonary Arterial Hypertension (PAH) (WHO Group 1) to improve exercise ability and delay clinical worsening.ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Endothelin-1 (ET-1) is a potent autocrine and paracrine peptide. Two receptor subtypes, ETA and ETB, mediate the effects of ET-1 in the vascular smooth muscle and endothelium. The primary actions of ETA are vasoconstriction and cell proliferation, while the predominant actions of ETB are vasodilation, antiproliferation, and ET-1 clearance. Ambrisentan is a high-affinity ETA receptor antagonist with a high selectivity for the ETA versus ETB receptor (>4000-fold). The clinical impact of high selectivity for ETA is not known.The pharmacokinetics of Ambrisentan (S-Ambrisentan) in healthy subjects are dose proportional. The absolute bioavailability of Ambrisentan is not known. Ambrisentan is absorbed with peak concentrations occurring approximately 2 hours after oral administration in healthy subjects and PAH patients. Food does not affect its bioavailability. In vitro studies indicate that Ambrisentan is a substrate of P-gp. Ambrisentan is highly bound to plasma proteins (99%). The elimination of Ambrisentan is predominantly by non-renal pathways, but the relative contributions of metabolism and biliary elimination have not been well characterized. In plasma, the AUC of 4-hydroxymethyl Ambrisentan accounts for approximately 4% relative to parent Ambrisentan AUC. Thein vivo inversion of S-Ambrisentan to R-Ambrisentan is negligible. The mean oral clearance of Ambrisentan is 38 mL/min and 19 mL/min in healthy subjects and in PAH patients, respectively. Although Ambrisentan has a 15-hour terminal half-life, the mean trough concentration of Ambrisentan at steady-state is about 15% of the mean peak concentration and the accumulation factor is about 1.2 after long-term daily dosing, indicating that the effective half-life of Ambrisentan is about 9 hours.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adult dose: Initial treatment is 5 mg once daily, and can be increased to 10 mg once daily if 5 mg is tolerated. Ambrisentan may be administered with or without food.Pediatric patients: The safety and effectiveness of Ambrisentan in pediatric patients have not been established.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Multiple dose co-administration of Ambrisentan and Cyclosporine resulted in an approximately 2-fold increase in Ambrisentan exposure in healthy volunteers; therefore, limit the dose of Ambrisentan to 5 mg once daily when co-administered with Cyclosporine.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ambrisentan may cause fetal harm when administered to a pregnant woman. Ambrisentan is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus. Pregnancy must be excluded before the initiation of treatment with Ambrisentan and prevented during treatment and for one month after stopping treatment. Ambrisentan is contraindicated in patients with Idiopathic Pulmonary Fibrosis (IPF) including IPF patients with pulmonary hypertension (WHO Group 3).পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Decreases in hemoglobin concentration and hematocrit have followed administration of other endothelin receptor antagonists and were observed in clinical studies with Ambrisentanগর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category X. It is not known whether Ambrisentan is excreted in human milk. Breastfeeding while receiving Ambrisentan is not recommended.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Fluid Retention: Peripheral edema is a known class effect of endothelin receptor antagonists, and is also a clinical consequence of PAH and worsening PAH.Pulmonary Veno-occlusive Disease: If patients develop acute pulmonary edema during initiation of therapy with vasodilating agents such as Ambrisentan, the possibility of pulmonary veno-occlusive disease should be considered, and if con_rmed. Ambrisentan should be discontinued.
Hematological Changes: Decreases in hemoglobin concentration and hematocrit have followed administration of other endothelin receptor antagonists and were observed in clinical studies with Ambrisentan.
Hepatic impairment: Ambrisentan is not recommended in patients with moderate or severe hepatic impairment.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool and dry place, below 30°C. Protect from light and moisture.বিকল্প ব্র্যান্ড: Ambrisentan
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।